QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
A new study led by Vanderbilt University Medical Center investigators found new diagnoses of prostate cancer in the U.S. declined 28 percent in the year following the draft recommendation from the United States Preventive Services Task Force (USPSTF) against routine…
Men with mutations in the breast cancer genes BRCA1 and BRCA2 have a higher risk of developing prostate cancer than men who don’t carry these genetic mutations. IMPACT is an international study evaluating the use of targeted prostate cancer screening…
Beginning within 5 years of the widespread acceptance of PSA screening in the U.S., there was what to date has amounted to an 80% decrease in the percentage of men with metastatic cancer at diagnosis and a 50% decrease in…
Anew study at Harvard University offered insight on how diet may help improve the chances of survival for the nearly three million U.S. men living with prostate cancer. The study found that men with prostate cancer who eat a high-fat…
Tumor-associated macrophages (TAMs) are a type of cell that is found within most tumor masses. Circulating tumor cells (CTC) are shed from a primary tumor and circulate in the bloodstream. Some scientists believe that TAMs derived from primary tumors facilitate…
Dioxin is a highly toxic substance found in Agent Orange and some other herbicides. During the Vietnam War, the U.S. military sprayed large amounts of herbicides, including Agent Orange, in Vietnam, Laos, and other places to clear vegetation. Some troops…
Using Genetics to Prevent Delayed Biopsies in African American Men Dr. Catalona and other researchers conducted a study to evaluate whether genetic correction using genetic variants could reduce potentially unnecessary and/or delayed biopsies in African-American men. Certain genetic variants have…
Jim McNally spent the majority of his career living abroad. Now in retirement – and fully recovered from prostate cancer – he is enjoying all that Europe has to offer. Forty-five years ago, Jim McNally was a young man who…
Radiation therapy is the standard treatment for men whose prostate cancer returns after radical prostatectomy. However, a new trial found that combining salvage radiation therapy with hormone therapy (also known as androgen deprivation therapy, or ADT) significantly delayed disease progression…
The results reported on four of the trial’s nine treatment arms: The standard treatment group, in which men had at least 3 years of hormone therapy, with or without radiation therapy Standard treatment plus docetaxel chemotherapy for six 3-week cycles…
"*" indicates required fields
